Severe cytomegalovirus gastritis and hypogammaglobulinemia in a patient treated with pembrolizumab.

Authors

Federico Sottotetti, Giovanni Arpa, Lucrezia Spina, Andrea Premoli, Katerina Vjero, Laura Deborah Locati, Marco Vincenzo Lenti

Published in

European journal of gastroenterology & hepatology. Jun 03, 2026. Epub Jun 03, 2026.

Abstract

A 66-year-old man with stage IVB oesophageal carcinoma treated with cisplatin, 5-fluorouracil, and pembrolizumab developed gastric erosions and ulcers with lymphoplasmacytic and neutrophilic infiltrates suggestive of immune checkpoint inhibitor-induced gastritis. High-dose steroids yielded transient relief. Cytomegalovirus (CMV) DNA was later found in gastric biopsies; steroids were withdrawn, and 3 weeks of intravenous ganciclovir led to partial improvement. Subsequent haemorrhagic gastritis raised concern for underlying immunodeficiency; serum immunoglobulin G (IgG), IgA, and IgM were undetectable. Administration of intravenous immunoglobulins (0.8 g/kg) produced rapid clinical resolution. This case report underscores the need for tissue-based CMV testing and cautious steroid use in severe gastritis.

PMID:
42467928
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.